Latest Regulatory Affairs Stories
RAPS will host a virtual workshop featuring regulators and regulatory experts on current communications guidelines and expectations for companies marketing regulated healthcare products in the US. Rockville, MD, USA (PRWEB) April 23, 2013 The Regulatory Affairs Professionals Society (RAPS) will host a virtual workshop, Advertising, Promotion and Labeling: the US Regulated Environment, Monday, 29 April, 12:00–5:00 pm EDT. The program features regulators and regulatory experts on current...
- New executives will play key roles in company's growth in 2013- SAN DIEGO, April 2, 2013 /PRNewswire/ -- SynteractHCR, a leading full-service contract research organization (CRO), has hired two new senior executives to support the company's growth on a global scale following its recent merger. SynteractHCR has appointed Bill Pierce as chief information officer and Richard Paul as chief medical officer and vice president medical/regulatory affairs. Both were chosen for their...
SHORT HILLS, N.J., Feb. 14, 2013 /PRNewswire/ -- Today, Pharmalink Consulting announced the appointment and promotion of five consultants at their offices in the UK, US and India. The appointments, which have been made in response to strong business growth experienced during 2012, enhance Pharmalink's global network of Regulatory Affairs Consultants and strengthen their position as the leading independent provider of regulatory intelligence and support to the healthcare industry....
As global firms are expanding product portfolio into multiple countries at a faster pace, Regulatory Operations needs should be met at higher speed and in a cost effective manner. Hence, MakroCare Launched Regulatory Operations Center of Excellence to support Global BioPharma by giving different capacity building options/models. Newark, NJ (PRWEB) January 22, 2013 MakroCare today announced the opening of a Regulatory Operations Center of Excellence (ROCoE) to support the burgeoning...
( ) VALENCIA, Calif., Nov. 7, 2012 /PRNewswire/ -- Sanguine BioSciences, Inc., a biotechnology company providing transparency to patients in biomedical research, has named Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to its Clinical Advisory Board and Ethics Committee. Ms. Rosario's extensive experience in clinical development and human ethics in clinical trials qualifies her to be the first to join Sanguine's Clinical Advisory Board and Ethics...
ALLENTOWN, N.J., Sept. 14, 2012 /PRNewswire/ -- HireLifeScience.com, the premier career networking website for the Life Science industries, will host its third annual career fair at The NJ Convention and Exposition Center in Edison, NJ on September 18, 2012. Doors will open for qualified professionals at 11 a.m. and the event will conclude at 4 p.m. The event is being sponsored by Vertex Pharmaceuticals and Allergan. Other company exhibitors will include Novartis, Stryker, Johnson...
LAWRENCE, Mass., Sept. 10, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced Todd M. Snell has joined the Company as Senior Vice President of Quality Assurance, Regulatory & Clinical Affairs. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) "NxStage has a strong culture of compliance and tradition of high quality and excellence in delivering renal products to patients and...
The Regulatory Affairs Professionals Society announces that 203 regulatory professionals passed the Regulatory Affairs Certification (RAC) exam during the spring 2012 exam period, thereby earning the RAC, the only accredited, post-academic, professional credential for the healthcare product regulatory field. Rockville, MD, USA (PRWEB) August 31, 2012 The Regulatory Affairs Professionals Society (RAPS) has announced that 203 regulatory professionals recently earned the RAC credential by...
CHAPEL HILL, N.C., Aug. 17, 2012 /PRNewswire/ -- Regulatory Affairs groups face the monumental task of ensuring that companies comply with the plethora of global regulations pertaining to developing and marketing medical device products. These specialized groups largely rely on their own internal effectiveness and efficiencies to remain productive and support the organization's goals. Optimal resourcing and staffing help Regulatory Affairs groups in the medical device industry...
ANN ARBOR, Mich., May 14, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE Amex: SYN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today the appointment of Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs. In this position, Dr. Reed will be responsible for the design and implementation of all aspects of clinical development, including clinical trials, and will lead the...
